• The agreement with GEDiCube rebrands the company as a wholly-owned subsidiary under the name Renovaro.AI
• The combined company brings together two innovative platforms in AI and biotherapeutics to offer comprehensive solutions spanning early detection, diagnostic insights, and targeted immunotherapies, for cancer and other diseases
• The AI division intends to launch commercial products for early cancer detection and improved therapy selection in 2024 – rapidly expanding the largely untapped precision medicine market

In September, Renovaro Biosciences (NASDAQ: RENB), an advanced, preclinical biotechnology company focused on cell, gene, and immunotherapy, and GEDiCube Intl Ltd., an AI medical technology company, announced a definitive agreement for combination. Under the stock-for-stock agreement, GEDiCube will become a wholly-owned subsidiary of Renovaro. The company’s CEO, Dr. Mark Dybul, MD, recently sent a letter to Renovaro shareholders to provide an update on the union – sharing the vision of the combination and expressing appreciation for their ongoing support and investment (https://ibn.fm/yFhPk).

“We believe GEDiCube’s AI technology will enhance and accelerate the development of treatments we are currently pursuing as well as power the discovery of new therapeutic approaches for cancer and other diseases,” press releases from the combination announcement quote Dr. Dybul as saying (https://ibn.fm/V1UyG). “The combined company will have independent operating divisions that will allow each technology to move as quickly as possible to commercialization while the collaboration between divisions will aim to drive new advances in both AI and medicine.”

According to Dr. Dybul, the AI division intends to launch commercial products for early cancer detection and improved therapy selection in 2024 – rapidly expanding the precision medicine market, which Renovaro is positioned to capture a substantial share of the largely untapped market.

The immunotherapy division plans to start Phase 1/2 trials of its lead asset in the second half of 2024, a breakthrough approach Dr. Dybul believes could lead to emergency use authorization as soon as the end of 2027 – following the results of a Phase 2 clinical trial that will transform treatment for cancers with low survival rates, like pancreatic cancer.

The combined company brings together two innovative platforms in AI and biotherapeutics to offer comprehensive solutions spanning early detection, diagnostic insights, and targeted immunotherapies. GEDiCube’s award-winning AI technology has already shown the ability to detect lung cancer early with 95% accuracy by analyzing complex molecular data. The company’s proprietary platform searches for patterns across genomics, epigenomics, transcriptomics, and other omics layers to identify informative biomarkers for over 12 cancers thus far. The company will rebrand as Renovaro.AI as outlined in the combination agreement.

Renovaro’s strength is its advanced immunotherapy platform focused initially on some of the deadliest solid tumor cancers that have seen only marginal improvement in survival rates over the past several decades. The company’s patented approach modifies allogeneic dendritic cells to stimulate anti-tumor immunity specific to a patient’s genetic profile. Remarkably, Renovaro’s personalized vaccine technology has shown an 80-90% reduction in tumor size, and the company expects to start human trials during the second half of 2024.

In his letter to the company’s shareholders, Dr. Dybul underlines that, like any cutting-edge company, there will be challenges ahead – but that the need has never been greater for transformative solutions that the combination of Renovaro and GEDiCube can provide. Dr. Dybul believes that there is a vision, technology, and talent that can transform how cancer is detected and managed early on. The companies have an opportunity and responsibility to fundamentally transform the lives of patients and families across the globe and help define the future of medicine.

For more information, visit the company’s website at www.RenovaroBio.com.

NOTE TO INVESTORS: The latest news and updates relating to RENB are available in the company’s newsroom at https://ibn.fm/RENB

• Freight Technologies announced securing a Request for Quotation from a leading global pharmaceutical giant that awards the company 33 lanes of transport pharmaceutical goods from the United States to Canada and Mexico
• The Request for Quotation extends over seven months, and Fr8App will provide uninterrupted, end-to-end logistics solutions, including secure transport, tracking, and reporting for each load
• The company’s dedicated team of professionals will oversee this vital operation to guarantee the smooth and efficient delivery of the pharmaceutical company’s critical products

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), a technology company developing solutions to optimize and automate the supply chain process through its custom-developed, industry-leading freight-matching platform powered by AI and machine learning, recently announced securing a Request for Quotation (RFQ) from a leading global pharmaceutical giant. The pharmaceutical conglomerate is known for its commitment to global health and life-changing innovations and has chosen Fr8App as its trusted partner for crucial logistical operations (https://ibn.fm/vyOgV).

Under the terms of the RFQ, Fr8App has been awarded 33 lanes of transport pharmaceutical goods from the United States to Canada and Mexico. The project involves moving one to three loads daily per lane, ensuring timely and secure delivery of vital pharmaceutical products to their international locations. The project is a testament to Fr8Tech’s commitment to safety, reliability, and precision in logistical operations.

Javier Selgas, CEO of Fr8Tech, said, the company was proud and honored to have been chosen to undertake this vital logistics operation. “This achievement represents a significant step in our mission to provide world-class logistics services, especially in the pharmaceutical industry, where precision and reliability are paramount,” Selgas said. “Our team is ready and excited to meet the high expectations of our esteemed client.”

The duration of the RFQ extends over seven months, during which time Fr8App will provide uninterrupted, end-to-end logistics solutions, including secure transport, tracking, and reporting for each load. The company’s dedicated team of professionals will oversee this vital operation to guarantee the smooth and efficient delivery of the pharmaceutical company’s critical products.

Fr8Tech offers an entire solutions suite to shippers and carriers that leverages AI to provide cloud-based platforms aiming to automate over-the-road transportation processes. The suite effectively reduces human touch points, expedites load booking times, and includes:

• Fr8App – a B2B marketplace powered by AI and Machine Learning offering a real-time broker portal to connect shippers with qualified carriers
• Fr8Radar – A tracking solution providing shippers and carriers real-time locational data via Fr8app’s mobile solution or through integration with third-party GPS alternatives
• Fr8TMS – A transportation management system designed to help shippers manage their freight and all of the documents involved in shipping transactions, including invoices, customs documents, confirmation rates, and proof of deliveries
• Fr8FMS – A fleet management system allowing transportation companies to manage their fleets better, reduce operational costs, and provide better service to their customers
• Fr8Data – A data solution offering real-time dashboards and reports to shippers and carriers to increase visibility and control while supporting better business decisions
• Fr8Fleet – A platform that provides private fleet management, enabling large corporate shippers to purchase dedicated capacity secured by Fr8app in exchange for a fixed fee

The services available to shippers and carriers make it possible for Fr8Tech to showcase their extensive expertise and offering – making over-the-road transport more efficient and affordable. With the RFQ win, Fr8App continues to solidify its presence in the competitive logistics market while establishing itself as a trusted partner for global companies looking for the secure services it provides.

For more information, visit the company’s website at www.Fr8Technologies.com and its freight-matching platform information site at www.Fr8.App.

NOTE TO INVESTORS: The latest news and updates relating to FRGT are available in the company’s newsroom at https://ibn.fm/FRGT

Corporate Communications
IBN (InvestorBrandNetwork)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com

Leading industry academics, practitioners, and engineers, will gather at the QuantMinds International  2023 conference in London from November 13-16, 2023. They will discuss and share in-depth insights into the latest trends and cutting-edge technologies in quant finance for better scope in their future endeavours. Over 500 industry practitioners and academics, 110+ asset managers, and 8 out of the 10 top banks of Europe are expected to grace the event.

On the opening day of the summit on November 13, 2023, numerous workshops and interactive sessions will be held as follows:

• LLMs & Advanced ML Summit: Learn about the innovative applications, and join in the discussions to learn about future technologies
• Quant Invest Summit: Top bankers discuss tips to shape your quant fund, talking about topics ranging from Multi-Asset Class Investing to Tick Data Management
• Machine Learning and Finance Workshop:  Learn about the core issues and acquire skills in this field
• Volatility Modelling Workshop: Dr Julien Guyon will speak on volatility derivatives to variance curve models and rough volatility

For day 2, the main conference will feature speaker sessions and boardroom discussions on a wide spectrum of topics in this industry. Discuss the career of young quants, diversity and inclusion, model risk management practices for NLP, and more, at informative roundtable discussions, with guidance from quantitative analysis experts and bankers of reputed firms.

The esteemed speaker panel includes representatives from JP Morgan, BlackRock, Bank of America, University of Oxford, Bank of England, Citigroup, Barclays, MUFG, and more.

The conference will offer networking breaks where attendees can interact and connect with experts and peers for future business opportunities. Expert research and practitioner insights on applications of AI and ML technologies in quant will be a major area of discussion. 

To know more, please visit https://ibn.fm/wrCOn.

• The digital assets market is expected to reach US$56.42 billion by the end of 2023
• Diamond Lake Minerals’ mission is to facilitate SEC-registered tokens that allow people to easily invest, through stock, in an industry that can otherwise be confusing to newcomers
• The company offers investors cutting-edge technology, an experienced team, market potential, regulatory compliance, and a diverse portfolio

Digital assets are any valuable digital or virtual item, including cryptocurrency, digital tokens, non-fungible tokens (“NFTs”), and more, created, stored, and traded on a digital platform like blockchain. These digital assets are bought, sold, and traded like traditional assets. By the end of 2023, the digital assets market is expected to reach US$56.42 billion – driven by several factors transforming capital markets worldwide (https://ibn.fm/sodyF).

Diamond Lake Minerals (OTC: DLMI) is focused on a specific type of digital asset, SEC-registered security tokens, a form of cryptocurrency that represents fractions of assets that have real value (such as equity, a company, or real estate). The company is setting a new industry standard – with a mission of registering security tokens with the Securities and Exchange Commission (“SEC”) to ensure a legitimate and secure trading environment. Diamond Lake Minerals is committed to ensuring that all market participants can invest confidently by operating under a strict regulatory framework that adheres to guidelines set by various U.S. regulators.

When investing in Diamond Lake Materials, investors get the unique opportunity to invest in digital assets without the requirement of learning all of the details associated with this often-complex digital asset space. The company’s approach allows investors to gain exposure to the fast-growing digital security market through a familiar investment vehicle – purchasing stock.

Diamond Lake Materials offers investors:

• Cutting-edge Technology – employs state-of-the-art technology to develop and support digital assets and SEC-registered security tokens, setting a new standard for security and compliance.
• Experienced Team – Diamond Lake Minerals’ management team brings decades of diverse industry experience, which adeptly steers the company’s strategic direction in the digital asset space.
• Market Potential – the focus on SEC-registered security tokens positions the company to capture significant market shares in the rapidly growing digital asset ecosystem.
• Regulatory Compliance – Diamond Lake Minerals is committed to adhering to SEC regulations to ensure the legality of operations and instilling investor confidence.
• Diverse Portfolio – Even though the company primarily focuses on security tokens, its interests in other digital assets offer diversified investment potential.

The recent additions to the company’s board of directors position the company to dominate the digital asset space. The board and new CEO represent decades’ worth of experience in the industry with leadership roles to guide the company’s approach. The appointment of Brian J. Esposito as the company’s new CEO brings the backing of Esposito Intellectual Enterprises and its diverse access to the expertise of over 110 companies and 200 joint ventures, alongside the knowledge of over 25 industries.

As the digital asset industry transforms and evolves, Diamond Lake Minerals has created a business model that allows investors to take part in investing in digital assets through a hands-off approach – through the purchase of stock. The company is reducing the risk of not understanding the industry and allowing investors to become a part of a growing revolution in the digital security industry.

For more information, visit the company’s website at www.DiamondLakeMinerals.com, or LinkedIn page at www.LinkedIn.com/company/Diamond-Lake-Minerals/.

NOTE TO INVESTORS: The latest news and updates relating to DLMI are available in the company’s newsroom at https://ibn.fm/DLMI

• Lexaria, a global innovator in drug delivery platforms, recently announced plans to launch new human and animal studies examining whether its patented DehydraTECH(TM) technology can make GLP-1 drugs better
• Lexaria has previously demonstrated DehydraTECH’s overall potential in its DIAB-A22-1 animal study, which yielded weight loss, and improved triglyceride and cholesterol levels among diabetic-conditioned animals
• The company plans to replicate the results from this study while also exploring ways to improve the overall bioavailability of GLP-1 drugs for diabetes treatment and weight loss
• Lexaria management is optimistic that it will build on previous studies, replicate previous positive results, and improve the overall efficacy of GLP-1 drugs

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced plans to launch new human and animal studies that seek to examine its patented DehydraTECH(TM) technology’s potential on GLP-1 drugs for the treatment of diabetes and weight loss. This announcement follows the recent study results published on “New England Journal of Medicine,” which showed that 49 to 52 pounds weight loss was a common outcome across the 2,539 adult study participants (https://ibn.fm/ffvaN).

DehydraTECH has demonstrated, in many instances, significant improvement in how active pharmaceutical ingredients (“APIs”) enter the bloodstream with its strong bioavailability enhancing capabilities. Its unique and revolutionary approach has seen Lexaria granted 37 patents for the technology, ultimately safeguarding its applicability, given its growing list of applications ranging from nicotine delivery to NSAIDs, antiviral drugs, cannabinoids, vitamins, and more.

So far, DehydraTECH has demonstrated positive results in diabetes-related studies. Its DIAB-A22-1 animal study yielded at least three positive outcomes: weight loss plus improved triglyceride and cholesterol levels. Reduced body weight, specifically, was realized in just four days after the start of dosing with DehydraTECH-CBD, with peak results achieved nine days after dosing and maintained throughout the 8-week study duration (https://ibn.fm/2OIdi).

Lexaria looks to replicate these results with GLP-1 drugs while also exploring ways to make these drugs better. GLP-1 agonists have been known to help manage blood sugar levels in people with type 2 diabetes. They have also proven effective in treating obesity, a result which has been very much welcomed by consumers and the more than 37 million Americans currently living with diabetes. By doing so, Lexaria looks to carve out a significant market share in the diabetes drug market, projected to hit $82.93 billion in value by 2027 (https://ibn.fm/EbDOH).

This commitment builds on the work that Lexaria has been doing with DehydraTECH since 2014. It also reflects the technology’s potential and the company’s confidence in it. Thus far, studies have shown exceptional results, asserting Lexaria as a dominant figure in the drug delivery technology space. Its management is optimistic that as it heads into GLP-1 research, it will build on its previous studies, ultimately improving the overall efficacy of GLP-1 drugs and further demonstrating DehydraTECH’s potential.

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

Join the leading Industry practitioners and experts from all over the globe at the QuantMinds International 2023 at the InterContinental O2, London, November 13-16. The event will host 8 out of the 10 top banks of Europe. The event platform will witness over 500 top industry practitioners and academics with over 110 asset managers. The quant event will also feature the applications of AI and ML technologies in quant.

New players, freshers, and upcoming firms, can avail this important opportunity to learn new practices and insights in quant, namely pricing and volatility, alpha generation, and machine learning, from thought leaders and experts of global acclaim.

The conference offers:

• A huge networking opportunity to connect with the industry peers, and learn the intricacies of quant from the stalwarts attending the event
• Expert research and practitioner insights on derivatives & volatility, portfolio optimization, computational finance, credit risk, alpha investing, inflation & interest rates, model risk, regulation & clearing, and more
• Insights on macro trends and micro developments to take your projects ahead in 2023
• Tips from the advisory board that includes representatives of Bloomberg L.P., University of Leuven, University of Sussex, MUFG, Citi, Amundi, University of Oxford, Commerzbank AG & more!
• Personal discussions, interactive Q&A with speakers, and dedicated networking breaks where attendees can network with each other
• In-depth analysis and insights on interest rates, crypto risks, FX and commodities, automation in the equity market and much more

After the Chair’s welcome remarks, the panel will discuss the regulatory report for 2024, followed by a discussion on the use of quantum for collateral optimization, will AI and ML replace quants, and more.

For additional information, visit https://ibn.fm/wrCOn.

• D-Wave’s new open-source demonstration highlights how its Advantage(TM) quantum computing system can be used to tackle challenges in wireless channel decoding, a growing worldwide problem given the dramatic global growth in wireless connections
• Demonstration shows quantum computing’s ability to tackle challenges of this magnitude relative to classical computation
• Quantum and quantum-hybrid technologies offer value in helping network providers solve a variety of telco-related optimization problems

D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software and services, and the world’s first commercial supplier of quantum computers, recently announced the launch of a new open-source demonstration that highlights how its Advantage(TM) annealing quantum computing system can be used to tackle wireless channel decoding problems. The demo, available through the company’s Leap(TM) real-time quantum cloud service, identifies solutions for increasing transmission capacity for wireless and cellular networks using coordinated multipoint decoding.

As the number of mobile connections worldwide approaches 12 billion, the wireless industry requires new solutions to ensure high-quality service levels while reducing operational costs and power requirements. This newly launched demonstration shows how D-Wave’s annealing quantum processing unit (“QPU”) can improve transmission performance and reduce transmission errors, particularly in dense urban areas characterized by high noise and load. D-Wave’s demo runs in a Jupyter notebook, accessible on GitHub (https://ibn.fm/SIrGM) and the Leap quantum cloud service (https://ibn.fm/JgISJ).

Trevor Lanting, vice president of software, algorithms, and cloud services at D-Wave, said a wide variety of companies spanning a diverse set of industries recognize the value D-Wave’s technology can bring to driving operational excellence (https://ibn.fm/RKqQY). “In the world of wireless telecommunications, the high degree of complexity and large number of variables means a massive amount of computational power is required to solve challenging problems like increasing transmission capacity,” Lanting explained. “Our demonstration shows how well our annealing quantum computing system can tackle challenges of this magnitude relative to classical computation, which could be transformative to network service providers.”

The demonstration is the latest example of the company’s practical applicability of its quantum and quantum-classical hybrid solutions for the telecommunications industry. D-Wave recently announced work with LG U+, the Korea Advanced Institute of Science and Technology (“KAIST”), and Qunova Computing to propel the development of 6G low-earth-orbit satellite networks through connectivity of ground-to-satellite links (“SGLs”) and inter-satellite-links (“ISLs”). Other telecom-related applications that can benefit from the company’s quantum technologies include: employee scheduling for workforce resource management, network design and expansion planning, call center routing, scheduling and routing service vehicles, and more.

D-Wave’s customers interface with the company’s Advantage quantum computer through its Leap cloud service, which delivers real-time cloud-based access with enterprise-class performance and scalability. Using Leap, customers have developed quantum hybrid applications for use cases in manufacturing, logistics, financial services, life sciences, materials science, retail, and transportation, eliminating the need to wait hours, days, or even weeks to get viable answers to various problems. Its customer success stories demonstrate the company’s real-world value at a business scale (https://ibn.fm/8QmwS).

The company’s relentless pursuit of practical quantum computing has resulted in its technology being used by some of the world’s most advanced enterprises, including numerous Forbes Global 2000 companies. Commercial customers include blue-chip industry leaders like Mastercard, Deloitte, ArcelorMittal, Siemens Healthineers, Unisys, Accenture, BBVA, NEC Corporation, Pattison Food Group Ltd., DENSO, and Lockheed Martin. D-Wave owns one of the largest quantum computer intellectual property portfolios in the industry, including more than 210 issued U.S. patents and more than 100 peer-reviewed papers in leading scientific journals.

For more information, visit the company’s website at www.DWaveQuantum.com.

NOTE TO INVESTORS: The latest news and updates relating to QBTS are available in the company’s newsroom at https://ibn.fm/QBTS

Forward Looking Statements:

Certain statements in this press release are forward-looking, as defined in the Private Securities Litigation Reform Act of 1995. These statements involve risks, uncertainties, and other factors that may cause actual results to differ materially from the information expressed or implied by these forward-looking statements and may not be indicative of future results. Forward-looking statements in this press release include, but are not limited to, statements regarding the potential of D-Wave’s technology to improve transmission performance and reduce transmission errors and to out-perform classical computational methods with respect to challenges facing the telecom industry. These forward-looking statements are subject to a number of risks and uncertainties, including, among others, various factors beyond management’s control, including whether the demonstration is successfully translated into production use-cases; general economic conditions and other risks; the company’s ability to expand its customer base and the customer adoption of the company’s solutions; risks within D-Wave’s industry, including anticipated trends, growth rates, and challenges for companies engaged in the business of quantum computing and the markets in which they operate; the outcome of any legal proceedings that may be instituted against the company; risks related to the performance of the company’s business and the timing of expected business or financial milestones; unanticipated technological or project development challenges, including with respect to the cost and/or timing thereof; the performance of the company’s products; the effects of competition on the company’s business; the risk that the company will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; the risk that the company may never achieve or sustain profitability; the risk that the company is unable to secure or protect its intellectual property; volatility in the price of the company’s securities; the risk that the company’s securities will not maintain the listing on the NYSE; and the numerous other factors set forth in D-Wave’s Annual Report on Form 10-K for its fiscal year ended December 31, 2022 and other filings with the Securities and Exchange Commission. Undue reliance should not be placed on the forward-looking statements in this press release in making an investment decision, which are based on information available to the company on the date hereof. D-Wave undertakes no duty to update this information unless required by law.

• SuperCom, a global leading provider of traditional and digital identity solutions (“DIS”), is targeting the expanding demand for DIS, and cybersecurity generally, to assert its position as a growing market leader
• The DIS market is projected to be valued at $83.2 billion by 2028, representing a CAGR of 19.3% over the forecast period
• The growing reliance on technology to solve emerging serious security issues is set to be one of the key factors fueling this growth
• SuperCom, through its increasing list of offerings, is delivering unique secured solutions tailored to the security space, part of a mission to revolutionize the public sector worldwide

It is projected that by 2028, the Digital Identity Solutions (“DIS”) market will be valued at $83.2 billion, representing a CAGR of 19.3% over the forecast period (2023-2028). Experts have pointed out that this growth will be primarily driven by the growing demand for DIS in different sectors, including, but not limited to, government and defense, banks, retail and commerce, energy and utility, healthcare, IT and telecom (https://ibn.fm/HHc4U). As a first-mover, SuperCom (NASDAQ: SPCB) is looking to take advantage of this spreading demand to create value for its shareholders and assert its position as a leader in its segment.

Given the growing identity and authentication fraud incidents, governments worldwide have embarked on initiatives facilitating ID security. In the financial sector, account takeovers have been on the rise, resulting in financial losses of billions of dollars annually. In the third quarter of the 2023 calendar year alone, account takeover attacks saw a 354% increase year-over-year, affecting at least 24 million households in the U.S. or 22% of adults in the country (https://ibn.fm/fPZlk).

These factors have prompted more companies to ramp up DIS and bolster their overall cybersecurity infrastructure. Blockchain, machine learning (“ML”), and artificial intelligence (“AI”) are some of the recent entrants into this space, indicating a strong reliance on technology to solve emerging security issues. They have also proven DIS to be the next-generation solution to identity governance and administration that effectively establishes a trusted identity, unlike previous forms of identity that were considered the norm.

Companies and governments are forced to find the perfect balance between service experience and security with the growing reliance on online services. Researchers have also shown that proper digital identity can make a big difference in customer differentiation, retention, and satisfaction, which SuperCom understands perfectly.

Through its offerings, the company delivers secured solutions specifically tailored to address emerging issues in the security space. Its efforts represent the company’s general mission to revolutionize the public safety sector worldwide through data intelligence, proprietary monitoring technology, and complementary services.

For more information, visit the company’s website at www.SuperCom.com.

NOTE TO INVESTORS: The latest news and updates relating to SPCB are available in the company’s newsroom at http://ibn.fm/SPCB

• Eloro Resources has recently filed its NI43-101 technical report, designed to complement the release of its initial mining resource estimate (“MRE”) published in August 2023
• Designed to calculate the project’s net smelter value and the respective economic costs of production, an NI 43-101 technical report is a key resource when calculating the economic viability of developing a mining site
• Iska Iska was recently referred to as a ‘giant’ mining system by famed Bolivian geologist, Dr. Osvaldo Arce given the site’s substantial inferred resource deposits
• Relatively high NSR values – and moderate operational costs – have boosted optimism around the deposit’s economic potential

In early October 2019, Eloro Resources (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM), an exploration and mining company announced that it had signed a Letter of Intent, granting the company the option to acquire up to a 100% interest in the Iska Iska Polymetallic Property, a mineral concession nestled in the midst of Bolivia’s famed Potosi region and home to history’s most prolific silver deposit. Four years later and following an extensive programme of drill work amounting to over 96,000 metres of diamond drilling across 139 individual holes, Eloro Resources has filed its NI 43-101 technical report, in support of the company’s initial mineral resource estimate, published on August 19, 2023 (https://ibn.fm/ZXBkW). Prepared in conjunction with independent mining consultant, Micon International Limit, the NI-43-101 technical report seeks to provide an overview on the overall economic viability related to the potential exploitation and development of the Iska Iska deposit.

With Eloro Resources having uncovered the presence of silver, tin and zinc within the expanses of its 900 hectare site, the company has opted to employ the net smelter return (“NSR”) method to encompass the estimated dollar value which each metal contributes towards the total value of each tonne – a valuation technique designed to calculate the estimated ex-ante revenue generation capacity of a designated mining zone.

Initial findings have estimated an NSR for Iska Iska’s polymetallic domain (containing zinc, tin and silver) of $20.32/t for open pit mining and $42.23/t for underground mining versus NSR cut-off values (representing the cost of extraction and refining, below which mineral extraction would become economically unfeasible) of $9.20/t and $34.40/t, respectively. Meanwhile, the NSR for the Project’s tin domain has been appraised at a relatively more modest $12.22/t for open pit mining operations, albeit, representing a premium of over 100% relative to the tin domain’s NSR cut-off value of $6.00/t.

Eloro Resources separately revealed that its NSR cut-off values had been significantly reduced as a result of the positive impact derived from the companies ‘ore-sorting’ tests, wherein a significant proportion of the mineral ‘waste’ could be removed prior to submitting the ore for further refining, thereby increasing concentrator feed grades and reducing operating costs.

In addition to providing an update on the potential economic values related to the development of the Iska Iska Project, Eloro Resources also provided an updated estimate of the inferred mineral resource within the site – an update following the publication of its initial mineral estimate report published in August. Total in situ metal is now estimated to amount to 298 million ounces of silver, 4.09 million tonnes of zinc, 1.74 million tonnes of lead and 130,000 tonnes of tin with the majority of the inferred mineral resources likely to be upgraded to ‘indicated’ mineral resources on the back of continued exploration works.

For more information, visit the company’s website at www.EloroResources.com.

NOTE TO INVESTORS: The latest news and updates relating to ELRRF are available in the company’s newsroom at https://ibn.fm/ELRRF

• Canada-based strategic metals innovator Ucore Rare Metals Inc. is preparing to make the leap from proving its rare earth element (“REE”) separation technology to utilizing it in a commercial-scale facility, which the company is set to begin building this year in the United States
• REEs are metals critical to magnets used in modern technologies ranging from smartphones to electric vehicles and U.S. fighter jets
• Industry professionals and government officials have been troubled by the REE industry’s dependence on China for processing the difficult-to-extract metals from mined product, but Ucore’s platform aims to provide a more efficient and cost-effective solution
• Ucore has received a $4 million award from the U.S. Department of Defense to help it demonstrate its capabilities and potential for sustaining national interests in the face of tech espionage concerns between Western countries and China

The race to stop climate change in its tracks by reducing industrial and motor vehicle pollutants has long been stymied, in part, by the difficulty of refining metals vital to modern, greener technology, but Canadian critical technology metals supply chain innovator Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF) is positioning its proprietary RapidSX(TM) solvent extraction solution to overcome the obstacles and disrupt the market.

RapidSX(TM) is expected to match and improve on the standard CSX solvent refining process used by China in its market-dominating extraction of rare earth elements (“REEs”) from mined product to prepare them for use in high-grade magnets that convert power into motion for modern technologies that range from smartphones to electric vehicles and F-35 fighter jets.

Ucore has been proving RapidSX(TM) against the standard CSX process at a demonstration plant in Ontario and is preparing to begin construction this year on a commercial-scale facility in Louisiana that will process up to 2,000 metric tons of total rare earth oxides (“TREOs”) by early 2025, separating heavy and light rare earth elements, with scale growth to 7,500 tons in 2027 (https://ibn.fm/G98BL).

The Economic Times recently noted the difficulties mining companies have faced in trying to break free of their reliance on China for REE processing and seeking alternatives for REE processing. Ore may contain any of 17 REE metals, each of which are nearly the same size and atomic weight, making separation complex, the report notes. And the rare earths must be teased out in a specific order, preventing companies from cherry-picking specific elements they may want, it states.

“The rare earths refining process can be very finicky,” University of Arizona’s mining and geological engineering department chief Kray Luxbacker told the publication (https://ibn.fm/kEkoE). “There are just so many complex steps.”

International trade policy conflicts between China and other countries in recent years have heightened concerns about the world’s virtual dependence on Chinese industry for REE processing, however.

“If you can innovate and bring solutions to market that produce rare earths efficiently, you have a tremendous market opportunity” geopolitical consulting firm Horizon Advisory co-founder Nathan Picarsic added.

Ucore’s side-by-side comparison of RapidSX(TM) to CSX at its Ontario plant is designed to show that RapidSX(TM) is a more efficient and cost-effective REE processing method with a shorter overall processing time and lower construction and operation costs. The process results in REE products that are virtually indistinguishable from those made in facilities using CSX.

The facility has hosted tours that have included government personnel, and the company has received a $4 million award from the U.S. federal government to help it demonstrate the capabilities of its solution in sustaining national interests in the face of tech espionage concerns between the United States and China.

For more information, visit the company’s website at www.Ucore.com.

NOTE TO INVESTORS: The latest news and updates relating to UURAF are available in the company’s newsroom at https://ibn.fm/UURAF